{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["T2DM", "diabetic complications", "insulin resistance", "saponin monomers"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38715375", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "11"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "11"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/ptr.8229"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "07"}], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "38", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jul"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications.", "Pagination": {"StartPage": "3564", "EndPage": "3582", "MedlinePgn": "3564-3582"}, "Abstract": {"AbstractText": ["Type 2 diabetes mellitus (T2DM), a metabolic disease with persistent hyperglycemia primarily caused by insulin resistance (IR), has become one of the most serious health challenges of the 21st century, with considerable economic and societal implications worldwide. Considering the inevitable side effects of conventional antidiabetic drugs, natural ingredients exhibit promising therapeutic efficacy and can serve as safer and more cost-effective alternatives for the management of T2DM. Saponins are a structurally diverse class of amphiphilic compounds widely distributed in many popular herbal medicinal plants, some animals, and marine organisms. There are many saponin monomers, such as ginsenoside compound K, ginsenoside Rb1, ginsenoside Rg1, astragaloside IV, glycyrrhizin, and diosgenin, showing great efficacy in the treatment of T2DM and its complications in vivo and in vitro. However, although the mechanisms of action of saponin monomers at the animal and cell levels have been gradually elucidated, there is a lack of clinical data, which hinders the development of saponin-based antidiabetic drugs. Herein, the main factors/pathways associated with T2DM and the comprehensive underlying mechanisms and potential applications of these saponin monomers in the management of T2DM and its complications are reviewed and discussed, aiming to provide fundamental data for future high-quality clinical studies and trials."], "CopyrightInformation": "\u00a9 2024 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0009-0009-7132-3409"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Health Science Center, Yangtze University, Jingzhou, Hubei, China."}, {"Identifier": [], "Affiliation": "Qianjiang Central Hospital Affiliated to Yangtze University, Qianjiang, Hubei, China."}], "LastName": "Zhang", "ForeName": "Lvzhuo", "Initials": "L"}, {"Identifier": ["0009-0002-0249-975X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Health Science Center, Yangtze University, Jingzhou, Hubei, China."}, {"Identifier": [], "Affiliation": "Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China."}], "LastName": "He", "ForeName": "Shifeng", "Initials": "S"}, {"Identifier": ["0000-0001-6489-227X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Health Science Center, Yangtze University, Jingzhou, Hubei, China."}], "LastName": "Liu", "ForeName": "Lian", "Initials": "L"}, {"Identifier": ["0000-0001-7362-4074"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Health Science Center, Yangtze University, Jingzhou, Hubei, China."}, {"Identifier": [], "Affiliation": "Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China."}], "LastName": "Huang", "ForeName": "Jiangrong", "Initials": "J"}], "GrantList": [{"GrantID": "WJ2021Q015", "Agency": "The Health Commission of Hubei Province Scientific Research Project", "Country": ""}, {"GrantID": "2023AFB839", "Agency": "Nature Science Foundation of Hubei Province", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Saponins"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Saponins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abdul\u2010Ghani, M., & DeFronzo, R. A. (2023). Fasting hyperinsulinemia and obesity: Cause or effect. The Journal of Clinical Endocrinology and Metabolism, 108(10), e1151\u2013e1152. https://doi.org/10.1210/clinem/dgad118"}, {"Citation": "Abo El\u2010Magd, N. F., El\u2010Mesery, M., El\u2010Karef, A., & El\u2010Shishtawy, M. M. (2018). Glycyrrhizin ameliorates high fat diet\u2010induced obesity in rats by activating NrF2 pathway. Life Sciences, 193, 159\u2013170. https://doi.org/10.1016/j.lfs.2017.11.005"}, {"Citation": "Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23(6), 716\u2013724. https://doi.org/10.1016/j.chom.2018.05.003"}, {"Citation": "Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022). Type 2 diabetes. Lancet, 400(10365), 1803\u20131820. https://doi.org/10.1016/s0140-6736(22)01655-5"}, {"Citation": "Arslanian, S. A., Saad, R., Lewy, V., Danadian, K., & Janosky, J. (2002). Hyperinsulinemia in African\u2010American children: Decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes, 51(10), 3014\u20133019. https://doi.org/10.2337/diabetes.51.10.3014"}, {"Citation": "Behl, T., Gupta, A., Sehgal, A., Sharma, S., Singh, S., Sharma, N., Diaconu, C. C., Rahdar, A., Hafeez, A., Bhatia, S., Al\u2010Harrasi, A., & Bungau, S. (2021). A spotlight on underlying the mechanism of AMPK in diabetes complications. Inflammation Research, 70(9), 939\u2013957. https://doi.org/10.1007/s00011-021-01488-5"}, {"Citation": "Belke, D. D., Swanson, E. A., & Dillmann, W. H. (2004). Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes, 53(12), 3201\u20133208. https://doi.org/10.2337/diabetes.53.12.3201"}, {"Citation": "Boden, G. (2011). Obesity, insulin resistance and free fatty acids. Current Opinion in Endocrinology, Diabetes, and Obesity, 18(2), 139\u2013143. https://doi.org/10.1097/MED.0b013e3283444b09"}, {"Citation": "Cai, H. A., Huang, L., Zheng, L. J., Fu, K., Wang, J., Hu, F. D., & Liao, R. Y. (2019). Ginsenoside (Rg\u20101) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR\u201023a/IRF\u20101 axis. Life Sciences, 233, 116525. https://doi.org/10.1016/j.lfs.2019.05.081"}, {"Citation": "Cai, S., Chen, J., & Li, Y. (2020). Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF\u2010\u03baB pathway in mice. Immunobiology, 225(3), 151941. https://doi.org/10.1016/j.imbio.2020.151941"}, {"Citation": "Chatterjee, S., Khunti, K., & Davies, M. J. (2017). Type 2 diabetes. Lancet, 389(10085), 2239\u20132251. https://doi.org/10.1016/s0140-6736(17)30058-2"}, {"Citation": "Chen, F., & Song, J. (2021). Cardioprotective action of glycyrrhizin on diabetic rats with myocardial remodeling. Journal of Healthcare Engineering, 2021, 6343677. https://doi.org/10.1155/2021/6343677"}, {"Citation": "Chen, Q., Ren, D., Liu, L., Xu, J., Wu, Y., Yu, H., Liu, M., Zhang, Y., & Wang, T. (2022). Ginsenoside compound K ameliorates development of diabetic kidney disease through inhibiting TLR4 activation induced by microbially produced imidazole propionate. International Journal of Molecular Sciences, 23(21), 12863. https://doi.org/10.3390/ijms232112863"}, {"Citation": "Chen, W., Balan, P., & Popovich, D. G. (2019). Review of ginseng anti\u2010diabetic studies. Molecules, 24(24), 4501. https://doi.org/10.3390/molecules24244501"}, {"Citation": "Chen, X., Yang, Y., Liu, C., Chen, Z., & Wang, D. (2019). Astragaloside IV ameliorates high glucose\u2010induced renal tubular epithelial\u2010mesenchymal transition by blocking mTORC1/p70S6K signaling in HK\u20102 cells. International Journal of Molecular Medicine, 43(2), 709\u2013716. https://doi.org/10.3892/ijmm.2018.3999"}, {"Citation": "Chen, Y., Xu, X., Zhang, Y., Liu, K., Huang, F., Liu, B., & Kou, J. (2016). Diosgenin regulates adipokine expression in perivascular adipose tissue and ameliorates endothelial dysfunction via regulation of AMPK. The Journal of Steroid Biochemistry and Molecular Biology, 155, 155\u2013165. https://doi.org/10.1016/j.jsbmb.2015.07.005"}, {"Citation": "Cheng, S., Liang, S., Liu, Q., Deng, Z., Zhang, Y., Du, J., Zhang, Y., Li, S., Cheng, B., & Ling, C. (2018). Diosgenin prevents high\u2010fat diet\u2010induced rat non\u2010alcoholic fatty liver disease through the AMPK and LXR signaling pathways. International Journal of Molecular Medicine, 41(2), 1089\u20131095. https://doi.org/10.3892/ijmm.2017.3291"}, {"Citation": "Dong, J., Liang, W., Wang, T., Sui, J., Wang, J., Deng, Z., & Chen, D. (2019). Saponins regulate intestinal inflammation in colon cancer and IBD. Pharmacological Research, 144, 66\u201372. https://doi.org/10.1016/j.phrs.2019.04.010"}, {"Citation": "Dong, X., Kong, L., Huang, L., Su, Y., Li, X., Yang, L., Ji, P., Li, W., & Li, W. (2023). Ginsenoside Rg1 treatment protects against cognitive dysfunction via inhibiting PLC\u2010CN\u2010NFAT1 signaling in T2DM mice. Journal of Ginseng Research, 47(3), 458\u2013468. https://doi.org/10.1016/j.jgr.2022.12.006"}, {"Citation": "D'Souza, A. M., Johnson, J. D., Clee, S. M., & Kieffer, T. J. (2016). Suppressing hyperinsulinemia prevents obesity but causes rapid onset of diabetes in leptin\u2010deficient Lepob/ob mice. Molecular Metabolism, 5(11), 1103\u20131112. https://doi.org/10.1016/j.molmet.2016.09.007"}, {"Citation": "Du, N., Xu, Z., Gao, M., Liu, P., Sun, B., & Cao, X. (2018). Combination of ginsenoside Rg1 and astragaloside IV reduces oxidative stress and inhibits TGF\u2010\u03b21/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. Drug Design, Development and Therapy, 12, 3517\u20133524. https://doi.org/10.2147/dddt.S171286"}, {"Citation": "Du, Q., Zhang, S., Li, A., Mohammad, I. S., Liu, B., & Li, Y. (2018). Astragaloside IV inhibits adipose lipolysis and reduces hepatic glucose production via Akt dependent PDE3B expression in HFD\u2010fed mice. Frontiers in Physiology, 9, 15. https://doi.org/10.3389/fphys.2018.00015"}, {"Citation": "Erion, K. A., & Corkey, B. E. (2017). Hyperinsulinemia: A cause of obesity? Current Obesity Reports, 6(2), 178\u2013186. https://doi.org/10.1007/s13679-017-0261-z"}, {"Citation": "Espinosa\u2010Diez, C., Miguel, V., Mennerich, D., Kietzmann, T., S\u00e1nchez\u2010P\u00e9rez, P., Cadenas, S., & Lamas, S. (2015). Antioxidant responses and cellular adjustments to oxidative stress. Redox Biology, 6, 183\u2013197. https://doi.org/10.1016/j.redox.2015.07.008"}, {"Citation": "Fan, X., Tao, J., Zhou, Y., Hou, Y., Wang, Y., Gu, D., Su, Y., Jang, Y., & Li, S. (2019). Investigations on the effects of ginsenoside\u2010Rg1 on glucose uptake and metabolism in insulin resistant HepG2 cells. European Journal of Pharmacology, 843, 277\u2013284. https://doi.org/10.1016/j.ejphar.2018.11.024"}, {"Citation": "Fan, X., Zhang, C., Niu, S., Fan, B., Gu, D., Jiang, K., Li, R., & Li, S. (2019). Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high\u2010fat and high\u2010sugar by inhibiting inflammation. European Journal of Pharmacology, 854, 247\u2013255. https://doi.org/10.1016/j.ejphar.2019.04.027"}, {"Citation": "Fan, Y., Fan, H., Li, P., Liu, Q., Huang, L., & Zhou, Y. (2022). Mitogen\u2010activating protein kinase kinase kinase kinase\u20103, inhibited by astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis. Bioengineered, 13(5), 11517\u201311529. https://doi.org/10.1080/21655979.2022.2068822"}, {"Citation": "Fan, Y., Fan, H., Zhu, B., Zhou, Y., Liu, Q., & Li, P. (2019). Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes\u2010induced rats. BMC Complementary and Alternative Medicine, 19(1), 355. https://doi.org/10.1186/s12906-019-2728-9"}, {"Citation": "Feng, H., Zhu, X., Tang, Y., Fu, S., Kong, B., & Liu, X. (2021). Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome\u2010mediated inflammation. International Journal of Molecular Medicine, 48(2), 164. https://doi.org/10.3892/ijmm.2021.4996"}, {"Citation": "Fryk, E., Olausson, J., Mossberg, K., Strindberg, L., Schmelz, M., Brogren, H., Gan, L. M., Piazza, S., Provenzani, A., Becattini, B., Lind, L., Solinas, G., & Jansson, P. A. (2021). Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case\u2010control and a population\u2010based cohort study. eBioMedicine, 65, 103264. https://doi.org/10.1016/j.ebiom.2021.103264"}, {"Citation": "Galicia\u2010Garcia, U., Benito\u2010Vicente, A., Jebari, S., Larrea\u2010Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Mart\u00edn, C. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275"}, {"Citation": "Gao, Y., Ji, Y., Luo, Y., Sun, J., Sun, G., & Sun, X. (2020). Ginsenoside Rg1 prevents early diabetic retinopathy via reducing retinal ganglion cell layer and inner nuclear layer cell apoptosis in db/db mice. Annals of Translational Medicine, 8(5), 232. https://doi.org/10.21037/atm.2019.12.155"}, {"Citation": "Gong, P., Xiao, X., Wang, S., Shi, F., Liu, N., Chen, X., Yang, W., Wang, L., & Chen, F. (2021). Hypoglycemic effect of astragaloside IV via modulating gut microbiota and regulating AMPK/SIRT1 and PI3K/AKT pathway. Journal of Ethnopharmacology, 281, 114558. https://doi.org/10.1016/j.jep.2021.114558"}, {"Citation": "Gupta, D., Jetton, T. L., LaRock, K., Monga, N., Satish, B., Lausier, J., Peshavaria, M., & Leahy, J. L. (2017). Temporal characterization of \u03b2 cell\u2010adaptive and \u2010maladaptive mechanisms during chronic high\u2010fat feeding in C57BL/6NTac mice. The Journal of Biological Chemistry, 292(30), 12449\u201312459. https://doi.org/10.1074/jbc.M117.781047"}, {"Citation": "Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014). \u03b2\u2010Cell failure in type 2 diabetes: Postulated mechanisms and prospects for prevention and treatment. Diabetes Care, 37(6), 1751\u20131758. https://doi.org/10.2337/dc14-0396"}, {"Citation": "Han, B., & He, C. (2021). Targeting autophagy using saponins as a therapeutic and preventive strategy against human diseases. Pharmacological Research, 166, 105428. https://doi.org/10.1016/j.phrs.2021.105428"}, {"Citation": "Han, D. (2021). Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats. The Journal of International Medical Research, 49(3), 300060519841165. https://doi.org/10.1177/0300060519841165"}, {"Citation": "Han, Y., Su, Y., Han, M., Liu, Y., Shi, Q., Li, X., Wang, P., Li, W., & Li, W. (2023). Ginsenoside Rg1 attenuates glomerular fibrosis by inhibiting CD36/TRPC6/NFAT2 signaling in type 2 diabetes mellitus mice. Journal of Ethnopharmacology, 302, 115923. https://doi.org/10.1016/j.jep.2022.115923"}, {"Citation": "He, J., Cui, J., Shi, Y., Wang, T., Xin, J., Li, Y., Shan, X., Zhu, Z., & Gao, Y. (2023). Astragaloside IV attenuates high\u2010glucose\u2010induced impairment in diabetic nephropathy by increasing klotho expression via the NF\u2010\u03baB/NLRP3 Axis. Journal Diabetes Research, 2023, 7423661. https://doi.org/10.1155/2023/7423661"}, {"Citation": "He, J. Y., Hong, Q., Chen, B. X., Cui, S. Y., Liu, R., Cai, G. Y., Guo, J., & Chen, X. M. (2022). Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity. Acta Pharmacologica Sinica, 43(2), 342\u2013353. https://doi.org/10.1038/s41401-021-00788-0"}, {"Citation": "He, K. Q., Li, W. Z., Chai, X. Q., Yin, Y. Y., Jiang, Y., & Li, W. P. (2018). Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin\u2010induced diabetic rat model. International Journal of Molecular Medicine, 41(2), 1078\u20131088. https://doi.org/10.3892/ijmm.2017.3265"}, {"Citation": "Hou, S., Zhang, T., Li, Y., Guo, F., & Jin, X. (2017). Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK/SIRT1/PGC\u20101\u03b1 signaling in db/db mice. Journal Diabetes Research, 2017, 2865912. https://doi.org/10.1155/2017/2865912"}, {"Citation": "Hu, Y., Tang, W., Liu, W., Hu, Z., & Pan, C. (2022). Astragaloside IV alleviates renal tubular epithelial\u2010mesenchymal transition via CX3CL1\u2010RAF/MEK/ERK signaling pathway in diabetic kidney disease. Drug Design, Development and Therapy, 16, 1605\u20131620. https://doi.org/10.2147/DDDT.S360346"}, {"Citation": "Hua, S., Li, Y., Su, L., & Liu, X. (2016). Diosgenin ameliorates gestational diabetes through inhibition of sterol regulatory element\u2010binding protein\u20101. Biomedicine & Pharmacotherapy, 84, 1460\u20131465. https://doi.org/10.1016/j.biopha.2016.10.049"}, {"Citation": "Huang, L., Cai, H. A., Zhang, M. S., Liao, R. Y., Huang, X., & Hu, F. D. (2021). Ginsenoside Rg1 promoted the wound healing in diabetic foot ulcers via miR\u2010489\u20103p/Sirt1 axis. Journal of Pharmacological Sciences, 147(3), 271\u2013283. https://doi.org/10.1016/j.jphs.2021.07.008"}, {"Citation": "Hwang, Y. C., Oh, D. H., Choi, M. C., Lee, S. Y., Ahn, K. J., Chung, H. Y., Lim, S. J., Chung, S. H., & Jeong, I. K. (2018). Compound K attenuates glucose intolerance and hepatic steatosis through AMPK\u2010dependent pathways in type 2 diabetic OLETF rats. The Korean Journal of Internal Medicine, 33(2), 347\u2013355. https://doi.org/10.3904/kjim.2015.208"}, {"Citation": "Ji, P., Shi, Q., Liu, Y., Han, M., Su, Y., Sun, R., Zhou, H., Li, W., & Li, W. (2023). Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4\u2010MAPK pathway in T2DM mice. Renal Failure, 45(1), 2197075. https://doi.org/10.1080/0886022x.2023.2197075"}, {"Citation": "Jia, G., Hill, M. A., & Sowers, J. R. (2018). Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circulation Research, 122(4), 624\u2013638. https://doi.org/10.1161/circresaha.117.311586"}, {"Citation": "Ju, Y., Su, Y., Chen, Q., Ma, K., Ji, T., Wang, Z., Li, W., & Li, W. (2019). Protective effects of astragaloside IV on endoplasmic reticulum stress\u2010induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats. Biomedicine & Pharmacotherapy, 109, 84\u201392. https://doi.org/10.1016/j.biopha.2018.10.041"}, {"Citation": "Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444(7121), 840\u2013846. https://doi.org/10.1038/nature05482"}, {"Citation": "Kanchan, D. M., Somani, G. S., Peshattiwar, V. V., Kaikini, A. A., & Sathaye, S. (2016). Renoprotective effect of diosgenin in streptozotocin induced diabetic rats. Pharmacological Reports, 68(2), 370\u2013377. https://doi.org/10.1016/j.pharep.2015.10.011"}, {"Citation": "Khateeb, S., Albalawi, A., & Alkhedaide, A. (2022). Diosgenin modulates oxidative stress and inflammation in high\u2010fat diet\u2010induced obesity in mice. Diabetes, Metabolic Syndrome and Obesity, 15, 1589\u20131596. https://doi.org/10.2147/dmso.S355677"}, {"Citation": "Khosravi, Z., Sedaghat, R., Baluchnejadmojarad, T., & Roghani, M. (2019). Diosgenin ameliorates testicular damage in streptozotocin\u2010diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation. International Immunopharmacology, 70, 37\u201346. https://doi.org/10.1016/j.intimp.2019.01.047"}, {"Citation": "Kiasalari, Z., Rahmani, T., Mahmoudi, N., Baluchnejadmojarad, T., & Roghani, M. (2017). Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation. Biomedicine & Pharmacotherapy, 86, 654\u2013661. https://doi.org/10.1016/j.biopha.2016.12.068"}, {"Citation": "Lei, X., Zhang, B. D., Ren, J. G., & Luo, F. L. (2018). Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR\u2010378/TRAF5 signaling pathway. Life Sciences, 206, 77\u201383. https://doi.org/10.1016/j.lfs.2018.05.037"}, {"Citation": "Lei, X., Zhang, L., Li, Z., & Ren, J. (2018). Astragaloside IV/lncRNA\u2010TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats. Drug Design, Development and Therapy, 12, 2785\u20132793. https://doi.org/10.2147/dddt.S166525"}, {"Citation": "Leng, B., Li, C., Sun, Y., Zhao, K., Zhang, L., Lu, M. L., & Wang, H. X. (2020). Protective effect of astragaloside IV on high glucose\u2010induced endothelial dysfunction via inhibition of P2X7R dependent P38 MAPK signaling pathway. Oxidative Medicine and Cellular Longevity, 2020, 5070415. https://doi.org/10.1155/2020/5070415"}, {"Citation": "Leng, B., Tang, F., Lu, M., Zhang, Z., Wang, H., & Zhang, Y. (2018). Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF\u2010\u03baB signaling pathway. Life Sciences, 209, 111\u2013121. https://doi.org/10.1016/j.lfs.2018.07.053"}, {"Citation": "Li, B., Zhang, D. C., Li, X. W., Dong, X. N., Li, W. P., & Li, W. Z. (2022). Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice. Zhongguo Zhong Yao Za Zhi, 47(2), 476\u2013483. https://doi.org/10.19540/j.cnki.cjcmm.20210926.401"}, {"Citation": "Li, C. W., Deng, M. Z., Gao, Z. J., Dang, Y. Y., Zheng, G. D., Yang, X. J., Chao, Y. X., Cai, Y. F., & Wu, X. L. (2020). Effects of compound K, a metabolite of ginsenosides, on memory and cognitive dysfunction in db/db mice involve the inhibition of ER stress and the NLRP3 inflammasome pathway. Food & Function, 11(5), 4416\u20134427. https://doi.org/10.1039/c9fo02602a"}, {"Citation": "Li, H., Zhai, B., Sun, J., Fan, Y., Zou, J., Cheng, J., Zhang, X., Shi, Y., & Guo, D. (2021). Antioxidant, anti\u2010aging and organ protective effects of total saponins from Aralia taibaiensis. Drug Design, Development and Therapy, 15, 4025\u20134042. https://doi.org/10.2147/dddt.S330222"}, {"Citation": "Li, W., Li, H., Zheng, L., Xia, J., Yang, X., Men, S., Yuan, Y., & Fan, Y. (2023). Ginsenoside CK improves skeletal muscle insulin resistance by activating DRP1/PINK1\u2010mediated mitophagy. Food & Function, 14(2), 1024\u20131036. https://doi.org/10.1039/d2fo02026b"}, {"Citation": "Li, X., Li, Z., Dong, X., Wu, Y., Li, B., Kuang, B., Chen, G., & Zhang, L. (2023). Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36\u2010mediated ferroptosis. Phytotherapy Research, 37(7), 3042\u20133056. https://doi.org/10.1002/ptr.7798"}, {"Citation": "Liang, G. Z., Cheng, L. M., Chen, X. F., Li, Y. J., Li, X. L., Guan, Y. Y., & Du, Y. H. (2018). ClC\u20103 promotes angiotensin II\u2010induced reactive oxygen species production in endothelial cells by facilitating Nox2 NADPH oxidase complex formation. Acta Pharmacologica Sinica, 39(11), 1725\u20131734. https://doi.org/10.1038/s41401-018-0072-0"}, {"Citation": "Liang, M., Zhan, W., Wang, L., Bei, W., & Wang, W. (2023). Ginsenoside Rb1 promotes hepatic glycogen synthesis to ameliorate T2DM through 15\u2010PGDH/PGE2/EP4 signaling pathway. Diabetes, Metabolic Syndrome and Obesity, 16, 3223\u20133234. https://doi.org/10.2147/dmso.S431423"}, {"Citation": "Lin, X., & Li, H. (2021). Obesity: Epidemiology, pathophysiology, and therapeutics. Frontiers in Endocrinology, 12, 706978. https://doi.org/10.3389/fendo.2021.706978"}, {"Citation": "Liu, H., Chen, W., Lu, P., Ma, Y., Liang, X., & Liu, Y. (2021). Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway. Annals of Translational Medicine, 9(24), 1789. https://doi.org/10.21037/atm-21-6234"}, {"Citation": "Liu, Q., Zhang, F. G., Zhang, W. S., Pan, A., Yang, Y. L., Liu, J. F., Li, P., Liu, B. L., & Qi, L. W. (2017). Ginsenoside Rg1 inhibits glucagon\u2010induced hepatic gluconeogenesis through Akt\u2010FoxO1 interaction. Theranostics, 7(16), 4001\u20134012. https://doi.org/10.7150/thno.18788"}, {"Citation": "Liu, S., Hu, R., Du, J., Li, Y., & Li, X. (2022). Glycyrrhizin ameliorates vascular endothelial cell senescence by inhibiting HMGB1 in HFD/STZ\u2010induced diabetic rats and human umbilical vein endothelial cells. European Journal of Pharmacology, 931, 175196. https://doi.org/10.1016/j.ejphar.2022.175196"}, {"Citation": "Liu, X., Wang, W., Song, G., Wei, X., Zeng, Y., Han, P., Wang, D., Shao, M., Wu, J., Sun, H., Xiong, G., & Li, S. (2017). Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network. PLoS One, 12(8), e0182558. https://doi.org/10.1371/journal.pone.0182558"}, {"Citation": "Loboda, A., Sobczak, M., Jozkowicz, A., & Dulak, J. (2016). TGF\u2010\u03b21/Smads and miR\u201021 in renal fibrosis and inflammation. Mediators of Inflammation, 2016, 8319283. https://doi.org/10.1155/2016/8319283"}, {"Citation": "Lou, M. D., Li, J., Cheng, Y., Xiao, N., Ma, G., Li, P., Liu, B., Liu, Q., & Qi, L. W. (2019). Glucagon up\u2010regulates hepatic mitochondrial pyruvate carrier 1 through cAMP\u2010responsive element\u2010binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. British Journal of Pharmacology, 176(16), 2962\u20132976. https://doi.org/10.1111/bph.14758"}, {"Citation": "Lu, Z., Yao, Y., Wang, J., & Peng, J. Y. (2021). Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R/NLRP3 signal. International Immunopharmacology, 101, 108314. https://doi.org/10.1016/j.intimp.2021.108314"}, {"Citation": "Ma, L., Zhang, C., Wu, L., Qin, L., & Liu, T. (2022). Diosgenin reduces phosphodiesterase 3B (PDE3B) through AMP\u2010activated protein kinase/ mechanistic target of rapamycin (AMPK/mTOR) signaling pathway to ameliorate streptozotocin\u2010induced pancreatic \u03b2\u2010cell apoptosis and dysfunction. Bioengineered, 13(2), 2217\u20132225. https://doi.org/10.1080/21655979.2021.2023996"}, {"Citation": "Mahmoudi, N., Kiasalari, Z., Rahmani, T., Sanaierad, A., Afshin\u2010Majd, S., Naderi, G., Baluchnejadmojarad, T., & Roghani, M. (2021). Diosgenin attenuates cognitive impairment in streptozotocin\u2010induced diabetic rats: Underlying mechanisms. Neuropsychobiology, 80(1), 25\u201335. https://doi.org/10.1159/000507398"}, {"Citation": "Marrelli, M., Conforti, F., Araniti, F., & Statti, G. A. (2016). Effects of saponins on lipid metabolism: A review of potential health benefits in the treatment of obesity. Molecules, 21(10), 1404. https://doi.org/10.3390/molecules21101404"}, {"Citation": "Mehran, A. E., Templeman, N. M., Brigidi, G. S., Lim, G. E., Chu, K. Y., Hu, X., Botezelli, J. D., Asadi, A., Hoffman, B. G., Kieffer, T. J., Bamji, S. X., Clee, S. M., & Johnson, J. D. (2012). Hyperinsulinemia drives diet\u2010induced obesity independently of brain insulin production. Cell Metabolism, 16(6), 723\u2013737. https://doi.org/10.1016/j.cmet.2012.10.019"}, {"Citation": "Nie, K., Gao, Y., Chen, S., Wang, Z., Wang, H., Tang, Y., Su, H., Lu, F., Dong, H., & Fang, K. (2023). Diosgenin attenuates non\u2010alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6\u2010related fatty acid uptake. Phytomedicine, 111, 154661. https://doi.org/10.1016/j.phymed.2023.154661"}, {"Citation": "Nie, Q., Zhu, L., Zhang, L., Leng, B., & Wang, H. (2019). Astragaloside IV protects against hyperglycemia\u2010induced vascular endothelial dysfunction by inhibiting oxidative stress and calpain\u20101 activation. Life Sciences, 232, 116662. https://doi.org/10.1016/j.lfs.2019.116662"}, {"Citation": "Odeleye, O. E., de Courten, M., Pettitt, D. J., & Ravussin, E. (1997). Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes, 46(8), 1341\u20131345. https://doi.org/10.2337/diab.46.8.1341"}, {"Citation": "Oh, J. M., Kim, E., & Chun, S. (2019). Ginsenoside compound K induces Ros\u2010mediated apoptosis and Autophagic inhibition in human neuroblastoma cells in vitro and in vivo. International Journal of Molecular Sciences, 20(17), 4279. https://doi.org/10.3390/ijms20174279"}, {"Citation": "Page, M. M., & Johnson, J. D. (2018). Mild suppression of hyperinsulinemia to treat obesity and insulin resistance. Trends in Endocrinology and Metabolism, 29(6), 389\u2013399. https://doi.org/10.1016/j.tem.2018.03.018"}, {"Citation": "Peng, M., Wang, L., Su, H., Zhang, L., Yang, Y., Sun, L., Wu, Y., Ran, L., Liu, S., Yin, M., Li, S., & Chunyu, W. (2022). Ginsenoside Rg1 improved diabetes through regulating the intestinal microbiota in high\u2010fat diet and streptozotocin\u2010induced type 2 diabetes rats. Journal of Food Biochemistry, 46(10), e14321. https://doi.org/10.1111/jfbc.14321"}, {"Citation": "Perino, A., Demagny, H., Velazquez\u2010Villegas, L., & Schoonjans, K. (2021). Molecular physiology of bile acid signaling in health, disease, and aging. Physiological Reviews, 101(2), 683\u2013731. https://doi.org/10.1152/physrev.00049.2019"}, {"Citation": "Petersen, M. C., & Shulman, G. I. (2018). Mechanisms of insulin action and insulin resistance. Physiological Reviews, 98(4), 2133\u20132223. https://doi.org/10.1152/physrev.00063.2017"}, {"Citation": "Prasad, M., Jayaraman, S., Rajagopal, P., Veeraraghavan, V. P., Kumar, P. K., Piramanayagam, S., & Pari, L. (2022). Diosgenin inhibits ER stress\u2010induced inflammation in aorta via iRhom2/TACE mediated signaling in experimental diabetic rats: An in vivo and in silico approach. Chemico\u2010Biological Interactions, 358, 109885. https://doi.org/10.1016/j.cbi.2022.109885"}, {"Citation": "Qiao, Y., Fan, C. L., & Tang, M. K. (2017). Astragaloside IV protects rat retinal capillary endothelial cells against high glucose\u2010induced oxidative injury. Drug Design, Development and Therapy, 11, 3567\u20133577. https://doi.org/10.2147/dddt.S152489"}, {"Citation": "Qin, L., Wang, J., Zhao, R., Zhang, X., & Mei, Y. (2019). Ginsenoside\u2010Rb1 improved diabetic cardiomyopathy through regulating calcium signaling by alleviating protein O\u2010GlcNAcylation. Journal of Agricultural and Food Chemistry, 67(51), 14074\u201314085. https://doi.org/10.1021/acs.jafc.9b05706"}, {"Citation": "Qiu, Y. Y., & Tang, L. Q. (2016). Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacological Research, 114, 251\u2013264. https://doi.org/10.1016/j.phrs.2016.11.004"}, {"Citation": "Rayego\u2010Mateos, S., Rodrigues\u2010Diez, R. R., Fernandez\u2010Fernandez, B., Mora\u2010Fern\u00e1ndez, C., Marchant, V., Donate\u2010Correa, J., Navarro\u2010Gonz\u00e1lez, J. F., Ortiz, A., & Ruiz\u2010Ortega, M. (2023). Targeting inflammation to treat diabetic kidney disease: The road to 2030. Kidney International, 103(2), 282\u2013296. https://doi.org/10.1016/j.kint.2022.10.030"}, {"Citation": "Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022). Inflammation in obesity, diabetes, and related disorders. Immunity, 55(1), 31\u201355. https://doi.org/10.1016/j.immuni.2021.12.013"}, {"Citation": "Shen, Q., Fang, J., Guo, H., Su, X., Zhu, B., Yao, X., Wang, Y., Cao, A., Wang, H., & Wang, L. (2023). Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up\u2010regulated Nrf2\u2010ARE/TFAM signaling in diabetic kidney disease. Free Radical Biology & Medicine, 203, 45\u201357. https://doi.org/10.1016/j.freeradbiomed.2023.03.022"}, {"Citation": "Somayajulu, M., McClellan, S. A., Pitchaikannu, A., Bessert, D., Liu, L., Steinle, J., & Hazlett, L. D. (2021). Effects of glycyrrhizin treatment on diabetic cornea. Journal of Ocular Pharmacology and Therapeutics, 37(1), 12\u201323. https://doi.org/10.1089/jop.2020.0105"}, {"Citation": "Song, W., Wei, L., Du, Y., Wang, Y., & Jiang, S. (2018). Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF\u2010\u03baB/p38 signaling pathway in high\u2010fat diet/streptozotocin\u2010induced diabetic mice. International Immunopharmacology, 63, 227\u2013238. https://doi.org/10.1016/j.intimp.2018.07.027"}, {"Citation": "Staruschenko, A., Spires, D., & Palygin, O. (2019). Role of TRPC6 in progression of diabetic kidney disease. Current Hypertension Reports, 21(7), 48. https://doi.org/10.1007/s11906-019-0960-9"}, {"Citation": "Su, H., Tian, C. J., Wang, Y., Shi, J., Chen, X., Zhen, Z., Bai, Y., Deng, L., Feng, C., Ma, Z., & Liu, J. (2022). Ginsenoside Rb1 reduces oxidative/carbonyl stress damage and ameliorates inflammation in the lung of streptozotocin\u2010induced diabetic rats. Pharmaceutical Biology, 60(1), 2229\u20132236. https://doi.org/10.1080/13880209.2022.2140168"}, {"Citation": "Su, Y., Chen, Q., Ma, K., Ju, Y., Ji, T., Wang, Z., Li, W., & Li, W. (2019). Astragaloside IV inhibits palmitate\u2010mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression. Pharmacological Reports, 71(2), 319\u2013329. https://doi.org/10.1016/j.pharep.2018.12.008"}, {"Citation": "Sun, H., Wang, W., Han, P., Shao, M., Song, G., Du, H., Yi, T., & Li, S. (2016). Astragaloside IV ameliorates renal injury in db/db mice. Scientific Reports, 6, 32545. https://doi.org/10.1038/srep32545"}, {"Citation": "Sun, X., Duan, X., Wang, C., Liu, Z., Sun, P., Huo, X., Ma, X., Sun, H., Liu, K., & Meng, Q. (2017). Protective effects of glycyrrhizic acid against non\u2010alcoholic fatty liver disease in mice. European Journal of Pharmacology, 806, 75\u201382. https://doi.org/10.1016/j.ejphar.2017.04.021"}, {"Citation": "Suresh, P. S., Singh, P. P., Padwad, Y. S., & Sharma, U. (2021). Steroidal saponins from trillium govanianum as \u03b1\u2010amylase, \u03b1\u2010glucosidase, and dipeptidyl peptidase IV inhibitory agents. The Journal of Pharmacy and Pharmacology, 73(4), 487\u2013495. https://doi.org/10.1093/jpp/rgaa038"}, {"Citation": "Tang, S. C. W., & Yiu, W. H. (2020). Innate immunity in diabetic kidney disease. Nature Reviews. Nephrology, 16(4), 206\u2013222. https://doi.org/10.1038/s41581-019-0234-4"}, {"Citation": "Thakur, V., Alcoreza, N., Delgado, M., Joddar, B., & Chattopadhyay, M. (2021). Cardioprotective effect of glycyrrhizin on myocardial remodeling in diabetic rats. Biomolecules, 11(4), 569. https://doi.org/10.3390/biom11040569"}, {"Citation": "Thakur, V., Nargis, S., Gonzalez, M., Pradhan, S., Terreros, D., & Chattopadhyay, M. (2017). Role of glycyrrhizin in the reduction of inflammation in diabetic kidney disease. Nephron, 137(2), 137\u2013147. https://doi.org/10.1159/000477820"}, {"Citation": "Tian, F., Huang, S., Xu, W., Chen, L., Su, J., Ni, H., Feng, X., Chen, J., Wang, X., & Huang, Q. (2022). Compound K attenuates hyperglycemia by enhancing glucagon\u2010like peptide\u20101 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism. Journal of Ginseng Research, 46(6), 780\u2013789. https://doi.org/10.1016/j.jgr.2022.03.006"}, {"Citation": "Tian, F., Xu, W., Chen, L., Chen, T., Feng, X., Chen, J., Wei, D., & Huang, Q. (2022). Ginsenoside compound K increases glucagon\u2010like peptide\u20101 release and L\u2010cell abundance in db/db mice through TGR5/YAP signaling. International Immunopharmacology, 113, 109405. https://doi.org/10.1016/j.intimp.2022.109405"}, {"Citation": "Tian, W., Chen, L., Zhang, L., Wang, B., Li, X. B., Fan, K. R., Ai, C. H., Xia, X., Li, S. D., & Li, Y. (2017). Effects of ginsenoside Rg1 on glucose metabolism and liver injury in streptozotocin\u2010induced type 2 diabetic rats. Genetics and Molecular Research, 16(1), gmr16019463. https://doi.org/10.4238/gmr16019463"}, {"Citation": "Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sj\u00f6str\u00f6m, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155\u2013161. https://doi.org/10.2337/diacare.27.1.155"}, {"Citation": "Uzayisenga, R., Ayeka, P. A., & Wang, Y. (2014). Anti\u2010diabetic potential of Panax notoginseng saponins (PNS): A review. Phytotherapy Research, 28(4), 510\u2013516. https://doi.org/10.1002/ptr.5026"}, {"Citation": "Van den Bergh, A., Vanderper, A., Vangheluwe, P., Desjardins, F., Nevelsteen, I., Verreth, W., Wuytack, F., Holvoet, P., Flameng, W., Balligand, J. L., & Herijgers, P. (2008). Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness. Cardiovascular Research, 77(2), 371\u2013379. https://doi.org/10.1093/cvr/cvm001"}, {"Citation": "Wang, L. Y., Cheng, K. C., Li, Y., Niu, C. S., Cheng, J. T., & Niu, H. S. (2017). Glycyrrhizic acid increases glucagon like peptide\u20101 secretion via TGR5 activation in type 1\u2010like diabetic rats. Biomedicine & Pharmacotherapy, 95, 599\u2013604. https://doi.org/10.1016/j.biopha.2017.08.087"}, {"Citation": "Wang, T., Zhang, Z., Song, C., Sun, L., Sui, X., Qu, Q., & Liu, J. (2020). Astragaloside IV protects retinal pigment epithelial cells from apoptosis by upregulating miR\u2010128 expression in diabetic rats. International Journal of Molecular Medicine, 46(1), 340\u2013350. https://doi.org/10.3892/ijmm.2020.4588"}, {"Citation": "Wang, X., Gao, Y., Tian, N., Wang, T., Shi, Y., Xu, J., & Wu, B. (2019). Astragaloside IV inhibits glucose\u2010induced epithelial\u2010mesenchymal transition of podocytes through autophagy enhancement via the SIRT\u2010NF\u2010\u03baB p65 axis. Scientific Reports, 9(1), 323. https://doi.org/10.1038/s41598-018-36911-1"}, {"Citation": "Wang, X., Gao, Y., Tian, N., Zou, D., Shi, Y., & Zhang, N. (2018). Astragaloside IV improves renal function and fibrosis via inhibition of miR\u201021\u2010induced podocyte dedifferentiation and mesangial cell activation in diabetic mice. Drug Design, Development and Therapy, 12, 2431\u20132442. https://doi.org/10.2147/dddt.S170840"}, {"Citation": "Wang, Y. N., Zhao, S. L., Su, Y. Y., Feng, J. X., Wang, S., Liao, X. M., Wang, L. N., Li, J. C., Meng, P., Li, H. Y., & Zhang, Y. F. (2020). Astragaloside IV attenuates high glucose\u2010induced EMT by inhibiting the TGF\u2010\u03b2/Smad pathway in renal proximal tubular epithelial cells. Bioscience Reports, 40(6), BSR20190987. https://doi.org/10.1042/bsr20190987"}, {"Citation": "Wang, Z., Wu, Q., Wang, H., Gao, Y., Nie, K., Tang, Y., Su, H., Hu, M., Gong, J., Fang, K., & Dong, H. (2022). Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6. Phytomedicine, 104, 154276. https://doi.org/10.1016/j.phymed.2022.154276"}, {"Citation": "Wang, Z., Zhu, Y., Zhang, Y., Zhang, J., Ji, T., Li, W., & Li, W. (2020). Protective effects of AS\u2010IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM. Biomedicine & Pharmacotherapy, 127, 110081. https://doi.org/10.1016/j.biopha.2020.110081"}, {"Citation": "Wang, Z. C., Niu, K. M., Wu, Y. J., Du, K. R., Qi, L. W., Zhou, Y. B., & Sun, H. J. (2022). A dual Keap1 and p47phox inhibitor ginsenoside Rb1 ameliorates high glucose/ox\u2010LDL\u2010induced endothelial cell injury and atherosclerosis. Cell Death & Disease, 13(9), 824. https://doi.org/10.1038/s41419-022-05274-x"}, {"Citation": "Wu, Y., Ye, F., Lu, Y., Yong, H., Yin, R., Chen, B., & Yong, Y. (2018). Diosgenin glucoside protects against myocardial injury in diabetic mice by inhibiting RIP140 signaling. American Journal of Translational Research, 10(11), 3742\u20133749."}, {"Citation": "Xing, L., Fang, J., Zhu, B., Wang, L., Chen, J., Wang, Y., Huang, J., Wang, H., & Yao, X. (2021). Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPAR\u03b3\u2010klotho\u2010FoxO1 axis in diabetic nephropathy. Life Sciences, 269, 119068. https://doi.org/10.1016/j.lfs.2021.119068"}, {"Citation": "Xu, J., Dong, J., Ding, H., Wang, B., Wang, Y., Qiu, Z., & Yao, F. (2022). Ginsenoside compound K inhibits obesity\u2010induced insulin resistance by regulation of macrophage recruitment and polarization via activating PPAR\u03b3. Food & Function, 13(6), 3561\u20133571. https://doi.org/10.1039/d1fo04273d"}, {"Citation": "Xu, Y., Wang, N., Tan, H. Y., Li, S., Zhang, C., Zhang, Z., & Feng, Y. (2020). Panax notoginseng saponins modulate the gut microbiota to promote thermogenesis and beige adipocyte reconstruction via leptin\u2010mediated AMPK\u03b1/STAT3 signaling in diet\u2010induced obesity. Theranostics, 10(24), 11302\u201311323. https://doi.org/10.7150/thno.47746"}, {"Citation": "Yang, R., Jiang, X., He, X., Liang, D., Sun, S., & Zhou, G. (2020). Ginsenoside Rb1 improves cognitive impairment induced by insulin resistance through Cdk5/p35\u2010NMDAR\u2010IDE pathway. BioMed Research International, 2020, 3905719. https://doi.org/10.1155/2020/3905719"}, {"Citation": "Yang, X., Dong, B., An, L., Zhang, Q., Chen, Y., Wang, H., & Song, Z. (2021). Ginsenoside Rb1 ameliorates glycemic disorder in mice with high fat diet\u2010induced obesity via regulating gut microbiota and amino acid metabolism. Frontiers in Pharmacology, 12, 756491. https://doi.org/10.3389/fphar.2021.756491"}, {"Citation": "Ying, Y., Zhang, Y. L., Ma, C. J., Li, M. Q., Tang, C. Y., Yang, Y. F., Zeng, J. H., Huang, X. Y., Yi, J., Wang, X. M., He, Z. D., & Shu, X. S. (2019). Neuroprotective effects of ginsenoside Rg1 against hyperphosphorylated tau\u2010induced diabetic retinal neurodegeneration via activation of IRS\u20101/Akt/GSK3\u03b2 signaling. Journal of Agricultural and Food Chemistry, 67(30), 8348\u20138360. https://doi.org/10.1021/acs.jafc.9b02954"}, {"Citation": "Yu, H., Zhen, J., Yang, Y., Gu, J., Wu, S., & Liu, Q. (2016). Ginsenoside Rg1 ameliorates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress\u2010induced apoptosis in a streptozotocin\u2010induced diabetes rat model. Journal of Cellular and Molecular Medicine, 20(4), 623\u2013631. https://doi.org/10.1111/jcmm.12739"}, {"Citation": "Yu, M., Huang, H., Dong, S., Sha, H., Wei, W., & Liu, C. (2019). High mobility group box\u20101 mediates hippocampal inflammation and contributes to cognitive deficits in high\u2010fat high\u2010fructose diet\u2010induced obese rats. Brain, Behavior, and Immunity, 82, 167\u2013177. https://doi.org/10.1016/j.bbi.2019.08.007"}, {"Citation": "Yu, T., Robotham, J. L., & Yoon, Y. (2006). Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proceedings of the National Academy of Sciences of the United States of America, 103(8), 2653\u20132658. https://doi.org/10.1073/pnas.0511154103"}, {"Citation": "Zhang, C., Han, M., Zhang, X., Tong, H., Sun, X., & Sun, G. (2022). Ginsenoside Rb1 protects against diabetic cardiomyopathy by regulating the adipocytokine pathway. Journal of Inflammation Research, 15, 71\u201383. https://doi.org/10.2147/jir.S348866"}, {"Citation": "Zhang, H., Zhang, R., Chen, J., Shi, M., Li, W., & Zhang, X. (2017). High mobility group Box1 inhibitor glycyrrhizic acid attenuates kidney injury in streptozotocin\u2010induced diabetic rats. Kidney & Blood Pressure Research, 42(5), 894\u2013904. https://doi.org/10.1159/000485045"}, {"Citation": "Zhang, L., Li, R., Shi, W., Liang, X., Liu, S., Ye, Z., Yu, C., Chen, Y., Zhang, B., Wang, W., Lai, Y., Ma, J., Li, Z., & Tan, X. (2013). NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice. British Journal of Pharmacology, 170(2), 426\u2013439. https://doi.org/10.1111/bph.12292"}, {"Citation": "Zhang, M., Liu, W., Liu, Y., Zhang, Z., Hu, Y., Sun, D., Li, S., & Fang, J. (2023). Astragaloside IV inhibited podocyte pyroptosis in diabetic kidney disease by regulating SIRT6/HIF\u20101\u03b1 Axis. DNA and Cell Biology, 42(10), 594\u2013607. https://doi.org/10.1089/dna.2023.0102"}, {"Citation": "Zhang, W., Li, T., Zhang, X. J., & Zhu, Z. Y. (2020). Hypoglycemic effect of glycyrrhizic acid, a natural non\u2010carbohydrate sweetener, on streptozotocin\u2010induced diabetic mice. Food & Function, 11(5), 4160\u20134170. https://doi.org/10.1039/c9fo02114k"}, {"Citation": "Zhang, W. S., Pan, A., Zhang, X., Ying, A., Ma, G., Liu, B. L., Qi, L. W., Liu, Q., & Li, P. (2019). Inactivation of NF\u2010\u03baB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction. Nature Communications, 10(1), 4303. https://doi.org/10.1038/s41467-019-12351-x"}, {"Citation": "Zhang, X., Wang, L., Guo, R., Xiao, J., Liu, X., Dong, M., Luan, X., Ji, X., & Lu, H. (2021). Ginsenoside Rb1 ameliorates diabetic arterial stiffening via AMPK pathway. Frontiers in Pharmacology, 12, 753881. https://doi.org/10.3389/fphar.2021.753881"}, {"Citation": "Zhang, Y., Tao, C., Xuan, C., Jiang, J., & Cao, W. (2020). Transcriptomic analysis reveals the protection of astragaloside IV against diabetic nephropathy by modulating inflammation. Oxidative Medicine and Cellular Longevity, 2020, 9542165. https://doi.org/10.1155/2020/9542165"}, {"Citation": "Zhang, Z., Wang, J., Zhu, Y., Zhang, H., & Wang, H. (2019). Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism. Molecular Medicine Reports, 20(5), 4612\u20134622. https://doi.org/10.3892/mmr.2019.10716"}, {"Citation": "Zhao, Y., Li, W., & Zhang, D. (2021). Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus. Molecular Medicine Reports, 24(5), 755. https://doi.org/10.3892/mmr.2021.12395"}, {"Citation": "Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews. Endocrinology, 14(2), 88\u201398. https://doi.org/10.1038/nrendo.2017.151"}, {"Citation": "Zhong, Y., Li, Z., Jin, R., Yao, Y., He, S., Lei, M., Wang, X., Shi, C., Gao, L., & Peng, X. (2022). Diosgenin ameliorated type II diabetes\u2010associated nonalcoholic fatty liver disease through inhibiting de novo lipogenesis and improving fatty acid oxidation and mitochondrial function in rats. Nutrients, 14(23), 4994. https://doi.org/10.3390/nu14234994"}, {"Citation": "Zhong, Y., Liu, J., Sun, D., Guo, T., Yao, Y., Xia, X., Shi, C., & Peng, X. (2022). Dioscin relieves diabetic nephropathy via suppressing oxidative stress and apoptosis, and improving mitochondrial quality and quantity control. Food & Function, 13(6), 3660\u20133673. https://doi.org/10.1039/d1fo02733f"}, {"Citation": "Zhou, R., He, D., Zhang, H., Xie, J., Zhang, S., Tian, X., Zeng, H., Qin, Y., & Huang, L. (2023). Ginsenoside Rb1 protects against diabetes\u2010associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles. Journal of Ethnopharmacology, 303, 115997. https://doi.org/10.1016/j.jep.2022.115997"}, {"Citation": "Zhou, Y., & Xu, B. (2022). New insights into anti\u2010diabetes effects and molecular mechanisms of dietary saponins. Critical Reviews in Food Science and Nutrition, 63, 12372\u201312397. https://doi.org/10.1080/10408398.2022.2101425"}, {"Citation": "Zhu, Y., Qian, X., Li, J., Lin, X., Luo, J., Huang, J., & Jin, Z. (2019). Astragaloside\u2010IV protects H9C2(2\u20101) cardiomyocytes from high glucose\u2010induced injury via miR\u201034a\u2010mediated autophagy pathway. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 4172\u20134181. https://doi.org/10.1080/21691401.2019.1687492"}, {"Citation": "Zhu, Y., Su, Y., Zhang, J., Zhang, Y., Li, Y., Han, Y., Dong, X., Li, W., & Li, W. (2021). Astragaloside IV alleviates liver injury in type 2 diabetes due to promotion of AMPK/mTOR\u2010mediated autophagy. Molecular Medicine Reports, 23(6), 437. https://doi.org/10.3892/mmr.2021.12076"}], "Title": "REFERENCES"}], "History": [{"Year": "2024", "Month": "4", "Day": "20"}, {"Year": "2023", "Month": "6", "Day": "20"}, {"Year": "2024", "Month": "4", "Day": "22"}, {"Year": "2024", "Month": "7", "Day": "11", "Hour": "12", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "8", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "5", "Day": "8", "Hour": "1", "Minute": "44"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38715375", "10.1002/ptr.8229"]}}]}